- $99.24m
- $68.35m
- $0.01m
Annual cashflow statement for Genelux, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -13.6 | -16.4 | -5.21 | -28.3 | -29.9 |
| Depreciation | |||||
| Non-Cash Items | 5.5 | 5.16 | 2.77 | 10.8 | 7.66 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.381 | 4.08 | -1.69 | -3.28 | 0.751 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -7.21 | -6.58 | -3.57 | -20.3 | -21.2 |
| Capital Expenditures | -0.02 | 0 | -0.049 | -1.02 | -0.381 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -13.7 | -7.75 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.02 | 0 | -0.049 | -14.7 | -8.13 |
| Financing Cash Flow Items | — | — | -1.57 | -0.303 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 18.1 | -0.27 | -0.478 | 44 | 28.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 10.9 | -6.86 | -4.1 | 9.02 | -0.853 |